Rosalind Advisors, Inc. Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Rosalind Advisors, Inc. disclosed 20 stock positions valued at approximately $266.23M as of quarter-end June 30, 2026. The largest holdings include DELCATH SYSTEMS, INC., FENNEC PHARMACEUTICALS INC, and XERIS BIOPHARMA HOLDINGS INC.

Report Period
June 30, 2026
No. of Stocks
20
Portfolio Value
$266.23M
Holdings by Sector
Rosalind Advisors, Inc. Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
DELCATH SYSTEMS, INC.DCTHHealthcare15.61%3,300,389--$41,551,898
FENNEC PHARMACEUTICALS INCFENCHealthcare12.87%3,188,001+279,800+9.62%$34,271,011
XERIS BIOPHARMA HOLDINGS INCXERSHealthcare8.65%2,908,981-322,719-9.99%$23,039,130
SAVARA INCSVRAHealthcare7.35%3,178,121-25,600-0.80%$19,577,225
VERASTEM INCVSTMHealthcare5.72%3,986,509+1,848,034+86.42%$15,228,464
EYEPOINT PHARMACEUTICALS INCEYPTHealthcare5.31%988,230-48,507-4.68%$14,131,689
VAXCYTE INCPCVXHealthcare4.37%200,000-90,000-31.03%$11,626,000
CELLDEX THERAPEUTICS INCCLDXHealthcare2.80%200,000-130,000-39.39%$7,442,000
BIOCRYST PHARMACEUTICALS INCBCRXHealthcare2.71%721,504-201,553-21.84%$7,215,040
PROFOUND MEDICAL CORPPROFHealthcare2.07%828,118--$5,506,985
TALPHERA INCTLPHHealthcare2.00%5,169,501+1,815,585+54.13%$5,324,586
ATEA PHARMACEUTICALS INCAVIRHealthcare1.87%1,070,550-101,305-8.64%$4,978,058
MYOMO INCMYOHealthcare1.42%3,637,886-209,386-5.44%$3,783,401
OVID THERAPEUTICS INCOVIDHealthcare1.12%1,107,994--$2,980,504
ABIVAX SAABVXHealthcare1.04%20,869+20,869+100.00%$2,781,003
INSPIREMD INCNSPRHealthcare1.03%3,905,743--$2,734,411
KURA ONCOLOGY INCKURAHealthcare0.41%100,000--$1,097,000
AQUESTIVE THERAPEUTICS INCAQSTHealthcare0.39%250,000--$1,040,000
ONKURE THERAPEUTICS INCOKUROther0.26%150,000-293,763-66.20%$684,000
PEPGEN INCPEPGHealthcare0.24%350,000+350,000+100.00%$630,000
Showing 20 of 20 holdings in the latest reporting period.